Conduit Pharmaceuticals Inc. Common Stock CDT · Stock Open Conduit Pharmaceuticals Inc. Common Stock in new tab
Conduit Pharmaceuticals Inc. Common Stock Analysis (CDT)
Is Conduit Pharmaceuticals Inc. Common Stock a good investment? Conduit Pharmaceuticals Inc. Common Stock (CDT) is currently trading at 1.25 USD.
Investor FAQ
Does Conduit Pharmaceuticals Inc. Common Stock pay a dividend?
No, it does not currently pay a dividend.
What asset class is Conduit Pharmaceuticals Inc. Common Stock?
Conduit Pharmaceuticals Inc. Common Stock is classified as a Stock. You can compare it against its peer in the "Related Symbols" list.
Company Profile
CDT Equity Inc., a data-driven biopharmaceutical company, focuses on identifying, enhancing, and monetising therapeutic assets. The company's pipeline includes AZD1656, a glucokinase activator that is in Phase II trials for the treatment of autoimmune disorders, including uveitis, Hashimoto's thyroiditis, preterm labor, and renal transplant; AZD5658, which is in Phase I clinical trial for the treatment of Type 2 Diabetes Mellitus; and AZD5904, which has completed Phase I clinical trials for the treatment of idiopathic male infertility. It also provides treatments for inflammatory disorders, oncology, dermatology, rare diseases and animal health. The company was formerly known as Conduit Pharmaceuticals Inc. and changed its name to CDT Equity Inc. in August 2025. The company was founded in 2019 and is based in Naples, Florida.
| Split Date | Split Ratio to 1 |
|---|---|
| Jan. 27, 2025 | 1:100 |
| May 20, 2025 | 1:15 |
| Oct. 13, 2025 | 1:8 |
| March 27, 2026 | 1:25 |
| July 20, 2026 | 1:10 |
| Sept. 29, 2026 | 1:25 |
Community Discussion